New scan could spare patients unnecessary bone biopsies

NCT ID NCT05934994

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a detailed bone scan (SPECT-CT) can accurately tell if a single suspicious bone lesion is benign or malignant. Researchers will compare the scan results to biopsy findings in 68 adults. If the scan works well, it could help some people avoid the risks of an unnecessary biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Bone scan (SPECT-CT)

What this could lead to

If successful, this scan could help doctors safely rule out cancer in suspicious bone spots without needing a biopsy.

What could go wrong

This is a small, early-stage study (68 people) testing a new way to use an existing scan. It may not prove accurate enough to replace biopsies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE LESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHRU Nancy

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••